Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis
出版年份 2020 全文链接
标题
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis
作者
关键词
-
出版物
PSYCHOLOGICAL MEDICINE
Volume -, Issue -, Pages 1-11
出版商
Cambridge University Press (CUP)
发表日期
2020-01-29
DOI
10.1017/s0033291719003519
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
- (2018) Manoela V. Fogaça et al. NEUROPHARMACOLOGY
- Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis
- (2018) Gemma Modinos et al. NEUROPSYCHOPHARMACOLOGY
- Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
- (2018) Sagnik Bhattacharyya et al. JAMA Psychiatry
- OUP accepted manuscript
- (2017) SCHIZOPHRENIA BULLETIN
- Resting Hyperperfusion of the Hippocampus, Midbrain, and Basal Ganglia in People at High Risk for Psychosis
- (2016) Paul Allen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
- (2016) Cathrin Rohleder et al. Frontiers in Pharmacology
- Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
- (2015) Matthijs G. Bossong et al. PSYCHOPHARMACOLOGY
- Hippocampal dysfunction during declarative memory encoding in schizophrenia and effects of genetic liability
- (2015) Tara Pirnia et al. SCHIZOPHRENIA RESEARCH
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- Functional and Neuroanatomic Specificity of Episodic Memory Dysfunction in Schizophrenia
- (2015) J. Daniel Ragland et al. JAMA Psychiatry
- Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
- (2013) Scott A. Schobel et al. NEURON
- Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing
- (2012) Sagnik Bhattacharyya ARCHIVES OF GENERAL PSYCHIATRY
- Improvement of Brain Reward Abnormalities by Antipsychotic Monotherapy in Schizophrenia
- (2012) Mette Odegaard Nielsen et al. ARCHIVES OF GENERAL PSYCHIATRY
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function
- (2012) S Bhattacharyya et al. MOLECULAR PSYCHIATRY
- Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging
- (2012) Nathan L. Hutcheson et al. SCHIZOPHRENIA RESEARCH
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study
- (2011) O Howes et al. MOLECULAR PSYCHIATRY
- Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia
- (2011) Daniel J. Lodge et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Prefrontal Activation Deficits During Episodic Memory in Schizophrenia
- (2009) John D. Ragland et al. AMERICAN JOURNAL OF PSYCHIATRY
- Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol
- (2009) Sagnik Bhattacharyya et al. ARCHIVES OF GENERAL PSYCHIATRY
- Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol
- (2009) Paolo Fusar-Poli et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neurocognition in first-episode schizophrenia: A meta-analytic review.
- (2009) Raquelle I. Mesholam-Gately et al. NEUROPSYCHOLOGY
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Changes in prefrontal and amygdala activity during olanzapine treatment in schizophrenia
- (2009) Giuseppe Blasi et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Striatal Dopamine and Working Memory
- (2008) S. M. Landau et al. CEREBRAL CORTEX
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started